Scroll To Top
Health

Developing
countries to receive single-pill HIV drug


We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.

Pharmaceutical companies Gilead and Merck announced Friday that they would distribute Atripla--the FDA-approved once-daily HIV pill--to developing countries around the world.

"The FDA's rapid review and approval of Atripla will help to expedite access for adults infected with HIV-1 living in resource-limited parts of the world," said John Martin, Gilead's president and CEO.

The companies didn't specify which nations would receive the drug. Only one in five people in need of HIV treatment in low- and middle-income countries were receiving it by the end of 2005. (The Advocate)

The Point Foundation featuring Robyn a Point Scholar with doctorate in educationOut / Advocate Magazine - Alan Cumming and Jake Shears

From our Sponsors

Most Popular

Latest Stories

Outtraveler Staff